Modern principles of pregnancy management in patients with lymphomas
- 作者: Shmakov R.G.1, Akhmedova A.I.1, Polushkina E.S.1, Demina E.A.2, Mangasarova Y.K.3, Tumyan G.S.4, Vinogradova M.A.1, Kravchenko S.K.3, Zubkov V.V.1
-
隶属关系:
- National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov
- N.I. Pirogov National Medical and Surgical Center
- National Medical Research Center for Hematology
- N. N. Blokhin National Medical Research Center of Oncology
- 期: 编号 7 (2019)
- 页面: 40-48
- 栏目: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248538
- DOI: https://doi.org/10.18565/aig.2019.7.40-48
- ID: 248538
如何引用文章
详细
全文:
作者简介
Roman Shmakov
National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov
Email: r_shmakov@oparina4.ru
MD, professor, Director of the Institute of Obstetrics
Aminat Akhmedova
National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov
Email: akhmedovag@yandex.ru
postgraduate student
Evgeniya Polushkina
National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov
Email: e_polushkina@oparina4.ru
PhD, senior researcher
Elena Demina
N.I. Pirogov National Medical and Surgical Center
Email: drdemina@yandex.ru
MD, professor
Yana Mangasarova
National Medical Research Center for Hematology
Email: V.k.jana@mail.ru
PhD, senior researcher
Gayane Tumyan
N. N. Blokhin National Medical Research Center of Oncology
Email: gaytum@mail.ru
MD, professor
Maria Vinogradova
National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov
Email: mary-grape@yandex.ru
PhD, head of the Department of Reproductive Hematology and Clinical Hemostasiology
Sergey Kravchenko
National Medical Research Center for Hematology
Email: skkrav@mail.ru
PhD, associate professor, head of the Department of Intensive High-dose Chemotherapy for Hemoblastosis with a Hospital and Outpatient Facility
Vktor Zubkov
National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov
Email: v_zubkov@oparina4.ru
MD, head of the Department of Neonatology and Pediatrics
参考
- Lavi N., Horowitz N.A., Brenner B. An update on the management of hematologic malignancies in pregnancy. Womens Health (Lond). 2014; 10(3): 255-66.
- Cohen J.B., Blum K.A. Evaluation and management of lymphoma and leukemia in pregnancy. Clin. Obstet. Gynecol. 2011; 54(4): 556-66.
- de Haan J., Verheecke M., Van Calsteren K., Van Calster B., Shmakov R.G., Mhallem Gziri M. et al.; International Network on Cancer and Infertility Pregnancy (INCIP). Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. Lancet Oncol. 2018; 19(3): 337-46.
- Han S.N., Kesin V.I., Van Calsteren K., Petkonic S., Amattt F.; ESGO ‘Cancer in Pregnancy’ Task Force. Cancer in pregnancy: a survey of current clinical practice. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013; 167(1): 18-23.
- Aniles A., Neri N., Nam bo MJ. Hematological malignancies and pregnancy: treat or no treat during fnO trimester. Int. J. Cancer. 2012; 131(11): 2678-83.
- Azim H.A. Jr., Pavlidis N., Peccatori F.A. Treatment of the pregnantmother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: hematological tumors. Cancer Treat. Rev. 2500; 36(2): 110-21.
- Banranona V, Crnnors J.M. Hodgkin lymphoma in pregnancy. Curr. Hematol. Malig. Rep. 2013; 8(3): 211-17.
- Connors J.M. Challenging problems: coincident pregnancy, HIV infection, and older age. Hematol. Am. Saa. Hematol. Educ. Program. 2008: 334-9.
- Mahmoud H.K., Samra M.A., FatOy G.M. Hematologic malignancies during pregnancy: a review. J. Adv. Res. 2016; 7(4): 589-96.
- Peccatori F.A., Azim H.A. Jr., Orecchia R., Hoekstra H.J., Pavlidis N., Kesic V., Pentheroudakis G.; ESMO Guidelines Working Group. Сancer, pregnancy a nd fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2013; 24(Suppl. 6): vi160-70.
- Mandal P.K., Dolai T.K., Bagchi B., Ghosh M.K., Bose S., Bhattacharyya M. B cell suppression in newborn following treatment of pregnant diffuse large B-cell lymphoma patient with rituximab containing regimen. Indian J. Pediatr. 2014; 81(10): 1092-4.
- Chakravarty E.F., Murray E.R., Kelman A., Farmer P. Pregnancy outcomes after maternal exposure to rituximab. Blood. 2011; 117(5): 1499-506.
- Boere I., Lok C., Vandenbroucke T., Amant F. Cancer in pregnancy: safety and efficacy of systemic therapies. Curr. Opin. Oncol. 2017; 29(5): 328-34.
- Horowitz N.A., Lavi N., Nadir Y., Brenner B. Haematological malignancies in pregnancy: An overview with an emphasis on thrombotic risks. Thromb. Haemost. 2016; 116(4): 613-7.
- Eyre T.A., Lau I.J., Mackillop L., Collins G.P. Management and controversies of classical Hodgkin lymphomain pregnancy. Br. J. Haematol. 2015; 169(5): 613-30.
- Heit J.A., Kobbervig C.E., James A.H., Petterson T.M., Bailey K.R., Melton L.J. 3rd. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann. Intern. Med. 2005; 143(10): 697-706.
- Mandala M., Barni S., Prins M., Labianca R., Tondini C., Russo L. et al. Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial. Ann. Oncol. 2010; 21(4): 871-6.
- El-Messidi A., Patenaude V., Abenhaim H.A. Incidence and outcomes of women with Hodgkin’s lymphoma in pregnancy: a population-based study on 7.9 million births. J. Obstet. Gynaecol. Res. 2015; 41(4): 582-9.
- Nadir Y., Kenig Y., Drugan A., Zcharia E., Brenner B. Involvement of heparanase in vaginal and cesarean section deliveries. Thromb. Res. 2010; 126(6): e444-50.
- The Royal College of Obstetricians and Gynaecologists. Reducing the risk of venous thromboembolism during pregnancy and the puerperium. Green-top Guideline No. 37a. April 2015.
- Van Calsteren K., Heyns L., De Smet F., Van Eycken L., Gziri M.M., Van Gemert W. et al. Cancer during pregnancy: An analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J. Clin. Oncol. 2010; 28(4): 683-9.
- Amant F., Van Calsteren K., Halaska M.J., Gziri M.M., Hui W., Lagae L. et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol. 2012; 13(3): 256-64.
- AmantF., Vandenbroucke T., Verheecke M., FumagalliM., Halaska M.J., Boere I. et al. Pediatric outcome after maternal cancer diagnosed during pregnancy. N. Engl. J. Med. 2015; 373(19): 1824-34.